HSA
- Marketing authorisation holder: CHECKPOINT THERAPEUTICS INC
- Status: likely_approved
🇸🇬 Unloxcyt in Singapore
Unloxcyt (COSIBELIMAB) regulatory status in Singapore.
Marketing authorisation
Unloxcyt in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Singapore
Frequently asked questions
Is Unloxcyt approved in Singapore?
Yes. HSA has authorised it.
Who is the marketing authorisation holder for Unloxcyt in Singapore?
CHECKPOINT THERAPEUTICS INC holds the Singaporean marketing authorisation.